The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

BACKGROUND: PD-L1 expression and tumour mutational burden (TMB) are both associated with the responses of multiple tumours to immune checkpoint inhibitor (ICI) therapy. However, their prevalence and correlations may differ in different types of advanced solid tumours. METHODS: PD-L1 expression, TMB,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanhui, Wang, Yating, Luo, Hongli, Meng, Xue, Zhu, Wei, Wang, Di, Zeng, Hui, Zhang, Henghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397649/
https://www.ncbi.nlm.nih.gov/pubmed/32775040
http://dx.doi.org/10.1186/s40164-020-00173-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397649/
https://www.ncbi.nlm.nih.gov/pubmed/32775040
http://dx.doi.org/10.1186/s40164-020-00173-3

Ejemplares similares